![](https://endpts.com/wp-content/uploads/2023/09/Kris-Elverum-AIRNA.jpg)
Kris Elverum, AIRNA CEO
RNA editing startup AIRNA raises $60M for clinical trial in rare liver disease
One of the latest entrants to the RNA editing field has tripled its funding and plans to start a clinical trial in a rare liver …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.